These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31027105)

  • 1. A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Watanabe-Kusunoki K; Abe N; Nakazawa D; Karino K; Hattanda F; Fujieda Y; Nishio S; Yasuda S; Ishizu A; Atsumi T
    Medicine (Baltimore); 2019 Apr; 98(17):e15328. PubMed ID: 31027105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis?
    Zhang W; Liu X; Wang X; Ma H; Zhang P
    Medicine (Baltimore); 2024 Jul; 103(27):e38790. PubMed ID: 38968474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease.
    Aoki Y; Kitazawa K; Kobayashi H
    Paediatr Int Child Health; 2019 May; 39(2):142-145. PubMed ID: 29457989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
    Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.
    Hiruma M; Sasano Y; Watanabe N; Yoshihara A; Ishii S; Yaguchi Y; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2021 Feb; 68(2):145-151. PubMed ID: 32999132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Tanaka R; Shimojima Y; Moteki H; Kishida D; Ueno KI; Sekijima Y
    Intern Med; 2018 Oct; 57(20):3029-3033. PubMed ID: 29780146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propylthiouracil induced ANCA-associated vasculitis in a 14-year-old girl.
    Schamp V; Verfaillie C; Bonroy C; Vande Walle J; Raes A; Dehoorne J
    Acta Clin Belg; 2015 Apr; 70(2):127-9. PubMed ID: 25937486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
    Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
    Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil-Induced Anti-Neutrophil Cytoplasmic Antibody Vasculitis Presenting with Red Eye Followed by Pulmonary Hemorrhage: Diagnostic and Management Considerations.
    Alidoost M; Cheng J; Alpert DR
    Am J Case Rep; 2020 Dec; 21():e925200. PubMed ID: 33293503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Chen M; Gao Y; Guo XH; Zhao MH
    Nat Rev Nephrol; 2012 Jun; 8(8):476-83. PubMed ID: 22664738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.
    Koide S; Kitajima K; Yamazaki M; Ichikawa T; Komatsu M
    Intern Med; 2023 Jul; 62(13):1951-1955. PubMed ID: 36384900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
    Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.